ClinicalTrials.govpublic full text
Camrelizumab Plus R-CHOP Regimen in Untreated Primary Extranodal DLBCL
primary extranodal lymphoma, dlbcl
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 217014
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.